XML 24 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated and Combined Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
February 2015
July 2015
Preferred Stock
Series A Convertible Preferred Stock
Preferred Stock
Series A 1 Convertible Preferred Stock
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Common Stock
February 2015
Common Stock
July 2015
Additional Paid-in Capital
Additional Paid-in Capital
February 2015
Additional Paid-in Capital
July 2015
Receivables from Stockholder
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2013 $ (11,017)           $ 1     $ 2,200     $ (335)   $ (12,883)
Beginning balance, temporary equity at Dec. 31, 2013       $ 19,909 $ 2,768 $ 38,414                  
Beginning balance (in shares) at Dec. 31, 2013             12,004,000                
Beginning balance, temporary equity (in shares) at Dec. 31, 2013       46,356,000 5,538,000 43,529,000                  
Issuance of common stock, net of discounts and offering costs, Value 56,456           $ 1     56,455          
Issuance of common stock, net of discounts and offering costs, shares             5,750,000                
Issuance of preferred stock           $ 13,481                  
Issuance of preferred stock, shares           15,263,000                  
Interest income accrued on notes receivable from stockholder (2)                       (2)    
Repayment of notes receivable from stockholder 337                       $ 337    
Issuance of common stock upon vesting of restricted stock awards 20                 20          
Issuance of common stock upon vesting of restricted stock awards, shares             645,000                
Recapitalization (Note 2)             $ (1)     1          
Recapitalization, shares (Note 2)       (41,205,000) (4,923,000) (52,260,000) (11,346,000)                
Issuance of common stock upon vesting of stock awards—post Recapitalization 70                 70          
Issuance of common stock upon vesting of stock awards—post Recapitalization, shares             282,000                
Issuance of common stock for research and development expenses related to technology licensing option 750                 750          
Issuance of common stock for research and development expenses related to technology licensing option, shares             60,000                
Conversion of preferred stock $ 74,573     $ (19,909) $ (2,768) $ (51,895) $ 1     74,572          
Conversion of preferred stock, shares       (5,151,000) (615,000) (6,532,000) 12,298,000                
Issuance of common stock pursuant to stock option exercises, shares 0                            
Stock-based compensation expense $ 10,101                 10,101          
Net loss (28,006)                           (28,006)
Unrealized gain (loss) on available-for-sale securities (100)                         $ (100)  
Ending balance at Dec. 31, 2014 103,182           $ 2     144,169       (100) (40,889)
Ending balance (in shares) at Dec. 31, 2014             19,693,000                
Issuance of common stock, net of discounts and offering costs, Value   $ 69,487 $ 193,947         $ 1     $ 69,486 $ 193,947      
Issuance of common stock, net of discounts and offering costs, shares               4,147,000 3,981,000            
Issuance of common stock upon vesting of restricted stock awards 80                 80          
Issuance of common stock upon vesting of restricted stock awards, shares             287,000                
RSU settlements, net of shares withheld (4,647)                 (4,647)          
RSU settlements, net of shares withheld, shares             327,000                
Issuance of common stock pursuant to stock option exercises $ 439                 439          
Issuance of common stock pursuant to stock option exercises, shares 23,822           24,000                
Stock-based compensation expense $ 10,251                 10,251          
Net loss (57,221)                           (57,221)
Unrealized gain (loss) on available-for-sale securities (418)                         (418)  
Ending balance at Dec. 31, 2015 315,100           $ 3     413,725       (518) (98,110)
Ending balance (in shares) at Dec. 31, 2015             28,459,000                
Issuance of common stock upon vesting of restricted stock awards 60                 60          
Issuance of common stock upon vesting of restricted stock awards, shares             233,000                
RSU settlements, net of shares withheld $ (94)                 (94)          
RSU settlements, net of shares withheld, shares             199,000                
Issuance of common stock pursuant to stock option exercises, shares 18,947                            
Issuance of common stock pursuant to employee stock awards $ 600                 600          
Issuance of common stock pursuant to employee stock awards, shares             42,000                
Stock-based compensation expense 16,784                 16,784          
Net loss (79,049)                           (79,049)
Unrealized gain (loss) on available-for-sale securities 335                         335  
Ending balance at Dec. 31, 2016 $ 253,736           $ 3     $ 431,075       $ (183) $ (177,159)
Ending balance (in shares) at Dec. 31, 2016             28,933,000